Pharmaceutical Technology in Hospital Pharmacy (Aug 2022)

Stability of voriconazole 10 mg/mL ophthalmic solution during 90 days

  • Khan Aasfa,
  • Venet Arnaud,
  • Bernadou Jean-Marc,
  • Cresto Sylvie,
  • Servant Vincent,
  • Boulestreau Hélène,
  • Xuereb Fabien,
  • Crauste-Manciet Sylvie

DOI
https://doi.org/10.1515/pthp-2021-0010
Journal volume & issue
Vol. 7, no. 1
pp. e307 – 13

Abstract

Read online

Fungal keratitis is a rare but severe cause of infectious keratitis and can lead to blindness. To cure fungal keratitis, antifungal like voriconazole eye drops must be immediately administered. As no brand is available on the market, voriconazole ophthalmic solution is compounded in hospital pharmacies using voriconazole powder for intravenous infusion. The aims of our study were to both assess the physico-chemical and microbiological stability of eye drop solutions stored at +2 to 8 °C. Two different High-Density-Polyethylene (HDPE) eye drop dispensing containers were assessed, one with a sterility preserving cap Novelia®(Nemera) and the other without sterility preserving cap both provided by CAT laboratory. In addition microbiological quality was assessed during 15 days simulated patient use.

Keywords